News

College football Top 25: Will No. 9 Alabama bounce back after missing CFP in Kalen DeBoer’s first year?

Finding more pass rush is key for Alabama in 2025. The Crimson Tide had just 25 sacks last season; Alabama hadn’t had fewer ...
CCN on MSN8m

7 Companies are Quietly Accumulating XRP in Their Treasuries—And You’d Never Guess Who

Seven public companies across various sectors have adopted XRP as a treasury reserve asset. Should Ripple adopt a treasury ...

Inspire Veterinary Partners Announces up to $10M in Financing at $1.00 per Share Through Cash and Transferred Securities

VIRGINIA BEACH, VA / ACCESS Newswire / August 4, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (“Inspire” or the ...

Small public companies snap up ether in new crypto gold rush, even as risks linger

Some companies are favoring ether over bitcoin as an inflation hedge as the cryptocurrency hits a sweet spot between ...

Razorbacks to make second go at meet-greet with Hogs fans

The last time the Razorbacks tried to set up an opportunity for players to meet and do autographs with fans, it devolved into one of ...
Fox Business on MSN43m

Expert touts SEC's 'Project Crypto' announcement: 'This is innovation'

The Digital Chamber Chair and founder Perianne Boring joins 'Mornings with Maria to react to SEC Chairman Paul Atkins ...

NCAA: No expansion of basketball tournaments beyond 68 teams this season, talks ongoing about 2027

The NCAA Tournament expanded from 64 to 68 teams in 2011. The change introduced the First Four round, a set of pre-tournament ...
Sooners Wire59m

Where do the Oklahoma Sooners land in Joel Klatt's preseason Top 25 list?

FOX Sports college football analyst and color commentator Joel Klatt released his preseason Top 25 rankings on Monday. The ...

Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors

Tharimmune, Inc. (NASDAQ:THAR), ("Tharimmune" or the "Company), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and ...